Literature DB >> 36050974

ISCHEMIA trial - a hundred million dollar 'Trial' under trial!

Om Prakash Yadava1.   

Abstract

Entities:  

Year:  2022        PMID: 36050974      PMCID: PMC9424479          DOI: 10.1007/s12055-022-01400-8

Source DB:  PubMed          Journal:  Indian J Thorac Cardiovasc Surg        ISSN: 0970-9134


× No keyword cloud information.
  5 in total

1.  Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.

Authors:  Deepak L Bhatt; P Gabriel Steg; Michael Miller
Journal:  N Engl J Med       Date:  2019-04-25       Impact factor: 91.245

2.  Mortality after multivessel revascularisation involving the proximal left anterior descending artery.

Authors:  Masafumi Ono; Hironori Hara; Chao Gao; Hideyuki Kawashima; Rutao Wang; Neil O'Leary; Joanna J Wykrzykowska; Jan J Piek; Michael J Mack; David Holmes; Marie-Claude Morice; Stuart Head; Arie Pieter Kappetein; Thilo Noack; Piroze M Davierwala; Friedrich W Mohr; Scot Garg; Yoshinobu Onuma; Patrick W Serruys
Journal:  Heart       Date:  2022-06-22       Impact factor: 5.994

3.  Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.

Authors:  Harmony R Reynolds; Leslee J Shaw; James K Min; Courtney B Page; Daniel S Berman; Bernard R Chaitman; Michael H Picard; Raymond Y Kwong; Sean M O'Brien; Zhen Huang; Daniel B Mark; Ranjit K Nath; Sudhanshu K Dwivedi; Paola E P Smanio; Peter H Stone; Claes Held; Matyas Keltai; Sripal Bangalore; Jonathan D Newman; John A Spertus; Gregg W Stone; David J Maron; Judith S Hochman
Journal:  Circulation       Date:  2021-09-09       Impact factor: 39.918

4.  Correction to: Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.

Authors: 
Journal:  Circulation       Date:  2022-05-20       Impact factor: 39.918

5.  Initial Invasive or Conservative Strategy for Stable Coronary Disease.

Authors:  David J Maron; Judith S Hochman; Harmony R Reynolds; Sripal Bangalore; Sean M O'Brien; William E Boden; Bernard R Chaitman; Roxy Senior; Jose López-Sendón; Karen P Alexander; Renato D Lopes; Leslee J Shaw; Jeffrey S Berger; Jonathan D Newman; Mandeep S Sidhu; Shaun G Goodman; Witold Ruzyllo; Gilbert Gosselin; Aldo P Maggioni; Harvey D White; Balram Bhargava; James K Min; G B John Mancini; Daniel S Berman; Michael H Picard; Raymond Y Kwong; Ziad A Ali; Daniel B Mark; John A Spertus; Mangalath N Krishnan; Ahmed Elghamaz; Nagaraja Moorthy; Whady A Hueb; Marcin Demkow; Kreton Mavromatis; Olga Bockeria; Jesus Peteiro; Todd D Miller; Hanna Szwed; Rolf Doerr; Matyas Keltai; Joseph B Selvanayagam; P Gabriel Steg; Claes Held; Shun Kohsaka; Stavroula Mavromichalis; Ruth Kirby; Neal O Jeffries; Frank E Harrell; Frank W Rockhold; Samuel Broderick; T Bruce Ferguson; David O Williams; Robert A Harrington; Gregg W Stone; Yves Rosenberg
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.